Neurogenetic Testing Market
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Neurogenetic Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 MRI
1.2.3 Next Generation Sequencing
1.2.4 Multiplex Ligation-dependent Probe Amplification (MLPA)
1.2.5 Fragment Analysis PCR
1.3 Market by Application
1.3.1 Global Neurogenetic Testing Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Research Institutes
1.3.5 Diagnostics Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Neurogenetic Testing Market Perspective (2017-2028)
2.2 Neurogenetic Testing Growth Trends by Region
2.2.1 Neurogenetic Testing Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Neurogenetic Testing Historic Market Size by Region (2017-2022)
2.2.3 Neurogenetic Testing Forecasted Market Size by Region (2023-2028)
2.3 Neurogenetic Testing Market Dynamics
2.3.1 Neurogenetic Testing Industry Trends
2.3.2 Neurogenetic Testing Market Drivers
2.3.3 Neurogenetic Testing Market Challenges
2.3.4 Neurogenetic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Neurogenetic Testing Players by Revenue
3.1.1 Global Top Neurogenetic Testing Players by Revenue (2017-2022)
3.1.2 Global Neurogenetic Testing Revenue Market Share by Players (2017-2022)
3.2 Global Neurogenetic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Neurogenetic Testing Revenue
3.4 Global Neurogenetic Testing Market Concentration Ratio
3.4.1 Global Neurogenetic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Neurogenetic Testing Revenue in 2021
3.5 Neurogenetic Testing Key Players Head office and Area Served
3.6 Key Players Neurogenetic Testing Product Solution and Service
3.7 Date of Enter into Neurogenetic Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Neurogenetic Testing Breakdown Data by Type
4.1 Global Neurogenetic Testing Historic Market Size by Type (2017-2022)
4.2 Global Neurogenetic Testing Forecasted Market Size by Type (2023-2028)
5 Neurogenetic Testing Breakdown Data by Application
5.1 Global Neurogenetic Testing Historic Market Size by Application (2017-2022)
5.2 Global Neurogenetic Testing Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Neurogenetic Testing Market Size (2017-2028)
6.2 North America Neurogenetic Testing Market Size by Country (2017-2022)
6.3 North America Neurogenetic Testing Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Neurogenetic Testing Market Size (2017-2028)
7.2 Europe Neurogenetic Testing Market Size by Country (2017-2022)
7.3 Europe Neurogenetic Testing Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Neurogenetic Testing Market Size (2017-2028)
8.2 Asia-Pacific Neurogenetic Testing Market Size by Country (2017-2022)
8.3 Asia-Pacific Neurogenetic Testing Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Neurogenetic Testing Market Size (2017-2028)
9.2 Latin America Neurogenetic Testing Market Size by Country (2017-2022)
9.3 Latin America Neurogenetic Testing Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Neurogenetic Testing Market Size (2017-2028)
10.2 Middle East & Africa Neurogenetic Testing Market Size by Country (2017-2022)
10.3 Middle East & Africa Neurogenetic Testing Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Labcorp
11.1.1 Labcorp Company Detail
11.1.2 Labcorp Business Overview
11.1.3 Labcorp Neurogenetic Testing Introduction
11.1.4 Labcorp Revenue in Neurogenetic Testing Business (2017-2022)
11.1.5 Labcorp Recent Development
11.2 Pacific Biosciences of California
11.2.1 Pacific Biosciences of California Company Detail
11.2.2 Pacific Biosciences of California Business Overview
11.2.3 Pacific Biosciences of California Neurogenetic Testing Introduction
11.2.4 Pacific Biosciences of California Revenue in Neurogenetic Testing Business (2017-2022)
11.2.5 Pacific Biosciences of California Recent Development
11.3 Victorian Clinical Genetics Services
11.3.1 Victorian Clinical Genetics Services Company Detail
11.3.2 Victorian Clinical Genetics Services Business Overview
11.3.3 Victorian Clinical Genetics Services Neurogenetic Testing Introduction
11.3.4 Victorian Clinical Genetics Services Revenue in Neurogenetic Testing Business (2017-2022)
11.3.5 Victorian Clinical Genetics Services Recent Development
11.4 MedGenome Labs
11.4.1 MedGenome Labs Company Detail
11.4.2 MedGenome Labs Business Overview
11.4.3 MedGenome Labs Neurogenetic Testing Introduction
11.4.4 MedGenome Labs Revenue in Neurogenetic Testing Business (2017-2022)
11.4.5 MedGenome Labs Recent Development
11.5 Blueprint Genetics
11.5.1 Blueprint Genetics Company Detail
11.5.2 Blueprint Genetics Business Overview
11.5.3 Blueprint Genetics Neurogenetic Testing Introduction
11.5.4 Blueprint Genetics Revenue in Neurogenetic Testing Business (2017-2022)
11.5.5 Blueprint Genetics Recent Development
11.6 GeneDx
11.6.1 GeneDx Company Detail
11.6.2 GeneDx Business Overview
11.6.3 GeneDx Neurogenetic Testing Introduction
11.6.4 GeneDx Revenue in Neurogenetic Testing Business (2017-2022)
11.6.5 GeneDx Recent Development
11.7 Mayo Clinic
11.7.1 Mayo Clinic Company Detail
11.7.2 Mayo Clinic Business Overview
11.7.3 Mayo Clinic Neurogenetic Testing Introduction
11.7.4 Mayo Clinic Revenue in Neurogenetic Testing Business (2017-2022)
11.7.5 Mayo Clinic Recent Development
11.8 Neurogene
11.8.1 Neurogene Company Detail
11.8.2 Neurogene Business Overview
11.8.3 Neurogene Neurogenetic Testing Introduction
11.8.4 Neurogene Revenue in Neurogenetic Testing Business (2017-2022)
11.8.5 Neurogene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Neurogenetic Testing Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of MRI
Table 3. Key Players of Next Generation Sequencing
Table 4. Key Players of Multiplex Ligation-dependent Probe Amplification (MLPA)
Table 5. Key Players of Fragment Analysis PCR
Table 6. Global Neurogenetic Testing Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Neurogenetic Testing Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Neurogenetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Neurogenetic Testing Market Share by Region (2017-2022)
Table 10. Global Neurogenetic Testing Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Neurogenetic Testing Market Share by Region (2023-2028)
Table 12. Neurogenetic Testing Market Trends
Table 13. Neurogenetic Testing Market Drivers
Table 14. Neurogenetic Testing Market Challenges
Table 15. Neurogenetic Testing Market Restraints
Table 16. Global Neurogenetic Testing Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Neurogenetic Testing Market Share by Players (2017-2022)
Table 18. Global Top Neurogenetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2021)
Table 19. Ranking of Global Top Neurogenetic Testing Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Neurogenetic Testing Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Neurogenetic Testing Product Solution and Service
Table 23. Date of Enter into Neurogenetic Testing Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Neurogenetic Testing Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Neurogenetic Testing Revenue Market Share by Type (2017-2022)
Table 27. Global Neurogenetic Testing Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Neurogenetic Testing Revenue Market Share by Type (2023-2028)
Table 29. Global Neurogenetic Testing Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Neurogenetic Testing Revenue Market Share by Application (2017-2022)
Table 31. Global Neurogenetic Testing Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Neurogenetic Testing Revenue Market Share by Application (2023-2028)
Table 33. North America Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Neurogenetic Testing Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Neurogenetic Testing Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Neurogenetic Testing Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Neurogenetic Testing Market Size by Country (2023-2028) & (US$ Million)
Table 43. Labcorp Company Detail
Table 44. Labcorp Business Overview
Table 45. Labcorp Neurogenetic Testing Product
Table 46. Labcorp Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 47. Labcorp Recent Development
Table 48. Pacific Biosciences of California Company Detail
Table 49. Pacific Biosciences of California Business Overview
Table 50. Pacific Biosciences of California Neurogenetic Testing Product
Table 51. Pacific Biosciences of California Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 52. Pacific Biosciences of California Recent Development
Table 53. Victorian Clinical Genetics Services Company Detail
Table 54. Victorian Clinical Genetics Services Business Overview
Table 55. Victorian Clinical Genetics Services Neurogenetic Testing Product
Table 56. Victorian Clinical Genetics Services Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 57. Victorian Clinical Genetics Services Recent Development
Table 58. MedGenome Labs Company Detail
Table 59. MedGenome Labs Business Overview
Table 60. MedGenome Labs Neurogenetic Testing Product
Table 61. MedGenome Labs Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 62. MedGenome Labs Recent Development
Table 63. Blueprint Genetics Company Detail
Table 64. Blueprint Genetics Business Overview
Table 65. Blueprint Genetics Neurogenetic Testing Product
Table 66. Blueprint Genetics Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 67. Blueprint Genetics Recent Development
Table 68. GeneDx Company Detail
Table 69. GeneDx Business Overview
Table 70. GeneDx Neurogenetic Testing Product
Table 71. GeneDx Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 72. GeneDx Recent Development
Table 73. Mayo Clinic Company Detail
Table 74. Mayo Clinic Business Overview
Table 75. Mayo Clinic Neurogenetic Testing Product
Table 76. Mayo Clinic Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 77. Mayo Clinic Recent Development
Table 78. Neurogene Company Detail
Table 79. Neurogene Business Overview
Table 80. Neurogene Neurogenetic Testing Product
Table 81. Neurogene Revenue in Neurogenetic Testing Business (2017-2022) & (US$ Million)
Table 82. Neurogene Recent Development
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Neurogenetic Testing Market Share by Type: 2021 VS 2028
Figure 2. MRI Features
Figure 3. Next Generation Sequencing Features
Figure 4. Multiplex Ligation-dependent Probe Amplification (MLPA) Features
Figure 5. Fragment Analysis PCR Features
Figure 6. Global Neurogenetic Testing Market Share by Application in 2021 & 2028
Figure 7. Hospitals Case Studies
Figure 8. Specialty Clinics Case Studies
Figure 9. Research Institutes Case Studies
Figure 10. Diagnostics Laboratories Case Studies
Figure 11. Neurogenetic Testing Report Years Considered
Figure 12. Global Neurogenetic Testing Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Neurogenetic Testing Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Neurogenetic Testing Market Share by Region: 2021 VS 2028
Figure 15. Global Neurogenetic Testing Market Share by Players in 2021
Figure 16. Global Top Neurogenetic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurogenetic Testing as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Neurogenetic Testing Revenue in 2021
Figure 18. North America Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. North America Neurogenetic Testing Market Share by Country (2017-2028)
Figure 20. United States Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Canada Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 22. Europe Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Europe Neurogenetic Testing Market Share by Country (2017-2028)
Figure 24. Germany Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Asia-Pacific Neurogenetic Testing Market Share by Region (2017-2028)
Figure 32. China Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Japan Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. South Korea Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Southeast Asia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. India Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Australia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Latin America Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Latin America Neurogenetic Testing Market Share by Country (2017-2028)
Figure 40. Mexico Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Brazil Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. Middle East & Africa Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Middle East & Africa Neurogenetic Testing Market Share by Country (2017-2028)
Figure 44. Turkey Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Saudi Arabia Neurogenetic Testing Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Labcorp Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 47. Pacific Biosciences of California Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 48. Victorian Clinical Genetics Services Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 49. MedGenome Labs Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 50. Blueprint Genetics Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 51. GeneDx Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 52. Mayo Clinic Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 53. Neurogene Revenue Growth Rate in Neurogenetic Testing Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Industry Market Size
